Fed­er­al judge sides with FDA on its mifepri­s­tone safe­ty pro­gram

The FDA act­ed with­in its purview when it main­tained some safe­ty re­quire­ments for the abor­tion pill mifepri­s­tone fol­low­ing an agency re­view, a fed­er­al court in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER